Oppilan Pharma Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://oppilan.com
Clinical Trials
4
Active:3
Completed:1
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Oppilan Pharma Ltd
- Target Recruit Count
- 213
- Registration Number
- NCT05156125
- Locations
- 🇺🇸
Local Site # 840030, Garden Grove, California, United States
🇺🇸Local Site # 840026, Lancaster, California, United States
🇺🇸Local Site # 840040, San Diego, California, United States
A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2021-05-28
- Lead Sponsor
- Oppilan Pharma Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT04451811
- Locations
- 🇬🇧
Celerion, Belfast, Northern Ireland, United Kingdom
News
No news found